Artesunate induces apoptosis, autophagy and ferroptosis in diffuse large B cell lymphoma cells by impairing STAT3 signaling

Artesunate inhibits melanoma progression in vitro via suppressing STAT3 signaling pathway

(2021) Mehmet Berköz et al.   Pharmacological Reports

Dimethyl fumarate induces ferroptosis and impairs NF-κB/STAT3 signaling in DLBCL

(2021) Anja Schmitt et al.   BLOOD

Targeting autophagy enhances the anticancer effect of artemisinin and its derivatives

(2019) Xin Sun et al.   MEDICINAL RESEARCH REVIEWS

Artesunate activates the ATF4-CHOP-CHAC1 pathway and affects ferroptosis in Burkitt's Lymphoma

(2019) Ning Wang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

STAT3 Interactors as Potential Therapeutic Targets for Cancer Treatment

(2018) Federica Laudisi et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Artesunate shows potent anti-tumor activity in B-cell lymphoma

(2018) Thea Kristin Våtsveen et al.   Journal of Hematology & Oncology

Diffuse large B-cell lymphoma

(2018) Shaoying Li et al.   PATHOLOGY

Long-term add-on therapy (compassionate use) with oral artesunate in patients with metastatic breast cancer after participating in a phase I study (ARTIC M33/2)

(2018) Cornelia von Hagens et al.   PHYTOMEDICINE

Artesunate and erythropoietin synergistically improve the outcome of experimental cerebral malaria

(2017) Yunting Du et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Artesunate induces apoptosis via inhibition of STAT3 in THP-1 cells

(2017) Mei Tan et al.   LEUKEMIA RESEARCH

Dihydroartemisinin and gefitinib synergistically inhibit NSCLC cell growth and promote apoptosis via the Akt/mTOR/STAT3 pathway

(2017) Hong Jin et al.   Molecular Medicine Reports

Induction of autophagy and autophagy-dependent apoptosis in diffuse large B-cell lymphoma by a new antimalarial artemisinin derivative, SM1044

(2017) Chunyan Cheng et al.   Cancer Medicine

The 2016 revision of the World Health Organization classification of lymphoid neoplasms

(2016) S. H. Swerdlow et al.   BLOOD

Ferroptosis: process and function

(2016) Y Xie et al.   CELL DEATH AND DIFFERENTIATION

Artesunate as an Anti-Cancer Agent Targets Stat-3 and Favorably Suppresses Hepatocellular Carcinoma

(2016) M. Ilamathi et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Artesunate attenuated progression of atherosclerosis lesion formation alone or combined with rosuvastatin through inhibition of pro-inflammatory cytokines and pro-inflammatory chemokines

(2016) Weiwei Jiang et al.   PHYTOMEDICINE

Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma

(2015) Ramona Crescenzo et al.   CANCER CELL

Activity of Artemisia annua and artemisinin derivatives, in prostate carcinoma

(2015) Friedrich-Wilhelm Michaelsen et al.   PHYTOMEDICINE

A Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal Cancer

(2015) Sanjeev Krishna et al.   EBioMedicine

Efficacy of intranasal administration of artesunate in experimental cerebral malaria

(2015) Anne Marijon et al.   MALARIA JOURNAL

Inhibition of autophagy by chloroquine potentiates synergistically anti-cancer property of artemisinin by promoting ROS dependent apoptosis

(2014) Arnab Ganguli et al.   BIOCHIMIE

How I treat primary CNS lymphoma

(2011) A. J. M. Ferreri   BLOOD

STAT3 SIGNALING: Anticancer Strategies and Challenges

(2011) P. A. Johnston et al.   MOLECULAR INTERVENTIONS

The Antiviral Activities of Artemisinin and Artesunate

(2008) Thomas Efferth et al.   CLINICAL INFECTIOUS DISEASES